Literature DB >> 18407594

Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C.

Ying Yuan1, Ichiro Shimizu, Mi Shen, Eriko Aoyagi, Hidetaka Takenaka, Tatuzo Itagaki, Mari Urata, Katsutaka Sannomiya, Nao Kohno, Katsuyoshi Tamaki, Masayuki Shono, Tetsuji Takayama.   

Abstract

AIM: To investigate the effects of estradiol (E2) and progesterone on the unstimulated and oxidative stress-stimulated production of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-8, and macrophage chemotactic protein (MCP)-1 by peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis C and healthy controls.
METHODS: The PBMCs were separated from age-matched 72 males and 71 females with and without chronic hepatitis C, who were divided into two groups based on a mean menopausal age of 50 years. Oxidative stress was induced by hydrogen peroxide in the cells incubated in serum-free media. Cytokines in the culture supernatant were measured by an enzyme-linked immunosorbent assay.
RESULTS: The highest levels of the spontaneous production of TNF-alpha, IL-1beta, IL-8, and MCP-1 by the unstimulated PBMCs were in the older male patients with chronic hepatitis C and the lowest levels were in the pre-menopausal female healthy controls. E2 inhibited the cytokine production by the unstimulated PBMCs from the older male and post-menopausal female patients, which was further stimulated by progesterone. The exposure to hydrogen peroxide in the PBMCs from the younger male and pre-menopausal female healthy subjects induced the production of cytokines. The change rates of the hydrogen peroxide-stimulated cytokine production were suppressed by E2 and enhanced by progesterone.
CONCLUSION: These findings suggest that E2 may play a favorable role in the course of persistent liver injury by preventing the accumulation of monocytes-macrophages and by inhibiting proinflammatory cytokine production, whereas progesterone may counteract the favorable E2 effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407594      PMCID: PMC2703845          DOI: 10.3748/wjg.14.2200

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Sex hormones and the immune response in humans.

Authors:  Annechien Bouman; Maas Jan Heineman; Marijke M Faas
Journal:  Hum Reprod Update       Date:  2005-04-07       Impact factor: 15.610

2.  Estrogens ameliorate remote organ inflammation induced by burn injury in rats.

Authors:  E S Ozveri; A Bozkurt; G Haklar; S Cetinel; S Arbak; C Yeğen; B C Yeğen
Journal:  Inflamm Res       Date:  2001-12       Impact factor: 4.575

3.  The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood.

Authors:  A Rogers; R Eastell
Journal:  Bone       Date:  2001-07       Impact factor: 4.398

4.  Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum.

Authors:  M Brännström; B E Fridén; M Jasper; R J Norman
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-04       Impact factor: 2.435

5.  Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells.

Authors:  T Itagaki; I Shimizu; X Cheng; Y Yuan; A Oshio; K Tamaki; H Fukuno; H Honda; Y Okamura; S Ito
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

6.  Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress.

Authors:  T Omoya; I Shimizu; Y Zhou; Y Okamura; H Inoue; G Lu; M Itonaga; H Honda; M Nomura; S Ito
Journal:  Liver       Date:  2001-06

7.  Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Authors:  Y Shiratori; S Shiina; M Imamura; N Kato; F Kanai; T Okudaira; T Teratani; G Tohgo; N Toda; M Ohashi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

8.  Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.

Authors:  L R You; C M Chen; Y H Lee
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women.

Authors:  S H Ralston; R G Russell; M Gowen
Journal:  J Bone Miner Res       Date:  1990-09       Impact factor: 6.741

10.  Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C.

Authors:  Zeki Karasu; Fatih Tekin; Galip Ersoz; Fulya Gunsar; Yucel Batur; Tankut Ilter; Ulus S Akarca
Journal:  Dig Dis Sci       Date:  2007-04-27       Impact factor: 3.487

View more
  12 in total

1.  Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.

Authors:  Eric Giannoni; Laurence Guignard; Marlies Knaup Reymond; Matthieu Perreau; Matthias Roth-Kleiner; Thierry Calandra; Thierry Roger
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.

Authors:  Jennifer C Lai; Elizabeth C Verna; Robert S Brown; Jacqueline G O'Leary; James F Trotter; Lisa M Forman; Jeffrey D Duman; Richard G Foster; R Todd Stravitz; Norah A Terrault
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

3.  Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.

Authors:  Ayako Suzuki; Huiman Barnhart; Jiezhun Gu; Herbert L Bonkovsky; Hans L Tillmann; Robert J Fontana; David E Kleiner
Journal:  Liver Int       Date:  2017-03-02       Impact factor: 5.828

4.  Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infection.

Authors:  Moataza H Omran; Basma E Fotouh; Samar S Youssef; Noha E Ibrahim; Wael Nabil; El-Sayed M Mahdy; Wafaa G Shosha; Mostafa K El-Awady
Journal:  World J Hepatol       Date:  2013-03-27

5.  Role of progesterone in TLR4-MyD88-dependent signaling pathway in pre-eclampsia.

Authors:  Ying Zhu; Min Wu; Chao-Ying Wu; Ge-Qing Xia
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

6.  Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection.

Authors:  Nora H Ahmed; Taghrid B El-Abaseri; Hesham F El-Sayed; Taher I El-Serafi
Journal:  Int J Chronic Dis       Date:  2015-08-17

7.  A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients.

Authors:  Moataza H Omran; Mahmoud Khamis; Nada Nasr; Ahmed A Massoud; Samar S Youssef; Noha G Bader El Din; Reham M Dawood; Khaled Atef; Rehab I Moustafa; Wael Nabil; Ashraf A Tabll; Mostafa K El Awady
Journal:  Hepat Mon       Date:  2013-12-19       Impact factor: 0.660

8.  Progesterone Modulation of Pregnancy-Related Immune Responses.

Authors:  Nishel M Shah; Nesrina Imami; Mark R Johnson
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

Review 9.  Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver.

Authors:  Luis E Soria-Jasso; Raquel Cariño-Cortés; Víctor Manuel Muñoz-Pérez; Elizabeth Pérez-Hernández; Nury Pérez-Hernández; Eduardo Fernández-Martínez
Journal:  Int J Mol Sci       Date:  2019-09-22       Impact factor: 5.923

10.  Meta-analysis of associations of IL1 receptor antagonist and estrogen receptor gene polymorphisms with systemic lupus erythematosus susceptibility.

Authors:  Li Cai; Jin-wei Zhang; Xing-xin Xue; Zhi-gang Wang; Jia-jia Wang; Shai-di Tang; Shao-wen Tang; Jie Wang; Yun Zhang; Xian Xia
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.